Sugammadex ED90 Dose in the Obese Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

January 31, 2014

Conditions
Incomplete Reversal of Neuromuscular Block
Interventions
DRUG

sugammadex ED90

"The first patient received the dose of 2.4 mg/kg and if there was a negative response, the next patient would be allocated to receive the next higher dose of 2.6 mg/kg.~In case that 2.4 mg/kg did produce a positive response, the next patient would be randomized with 10% of probability to receive the next dose of 2.2 mg/kg or 90% probability to receive the same dose of 2.4 mg/kg."

All Listed Sponsors
lead

Faculdade de Ciências Médicas da Santa Casa de São Paulo

OTHER

NCT02568345 - Sugammadex ED90 Dose in the Obese Patients | Biotech Hunter | Biotech Hunter